Verona Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VERONA PHARMA, and when can generic versions of VERONA PHARMA drugs launch?
VERONA PHARMA has one approved drug.
There are three US patents protecting VERONA PHARMA drugs.
There are sixty-eight patent family members on VERONA PHARMA drugs in thirty countries.
Drugs and US Patents for Verona Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Verona Pharma | OHTUVAYRE | ensifentrine | SUSPENSION;INHALATION | 217389-001 | Jun 26, 2024 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
Verona Pharma | OHTUVAYRE | ensifentrine | SUSPENSION;INHALATION | 217389-001 | Jun 26, 2024 | RX | Yes | Yes | 9,956,171 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Verona Pharma | OHTUVAYRE | ensifentrine | SUSPENSION;INHALATION | 217389-001 | Jun 26, 2024 | RX | Yes | Yes | 10,945,950 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Verona Pharma | OHTUVAYRE | ensifentrine | SUSPENSION;INHALATION | 217389-001 | Jun 26, 2024 | RX | Yes | Yes | 9,062,047 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Verona Pharma Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Cyprus | 1120264 | ⤷ Subscribe |
Taiwan | I516488 | ⤷ Subscribe |
South Korea | 101860968 | ⤷ Subscribe |
Slovenia | 3332767 | ⤷ Subscribe |
Serbia | 62252 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.